2 recruiting, 1 active not recruiting, 1 completed, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow this condition Literature Review of Nasopharyngeal Squamous Cell Carcinoma trials Research Report on Nasopharyngeal Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation Audiometric Test, Interview - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Not applicable | Recruiting | Emory University | 118 | 2025-08-25 | 2026-07-16 |
| Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer Best Practice, Biospecimen Collection, Cisplatin - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Recruiting | NRG Oncology | 98 | 2025-06-23 | 2026-08-17 |
| Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma Biopsy Procedure, Birinapant, Computed Tomography - Locally Recurrent Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 13 | 2019-09-25 | 2026-08-03 |
| Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma Docetaxel, Cisplatin, IMRT - Stage II, III, Nasopharyngeal Squamous Cell Carcinoma | Phase 2 / Phase 3 | Unknown | Chinese Academy of Medical Sciences | 120 | 2019-06-15 | 2021-01-29 |
| GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China gemcitabine and cisplatin, docetaxel and cisplatin - Nasopharyngeal Squamous Cell Carcinoma, Toxicity Due to Radiotherapy | Phase 2 | Completed | Air Force Military Medical University, China | 60 | 2012-05-01 | 2013-10-30 |
Carcinoma (2) · Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Mouth Neoplasms (2) · Nasopharyngeal Carcinoma (2) · Oropharyngeal Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Stomatitis (1)
Carcinoma, Squamous Cell (2) · Head and Neck Neoplasms (2) · Laryngeal Diseases (2) · Mouth Diseases (2) · Nasopharyngeal Diseases (2) · Nasopharyngeal Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Respiratory Tract Diseases (2)
Cisplatin (3) · Radiotherapy, Intensity-Modulated (3) · Docetaxel (2) · Magnetic Resonance Spectroscopy (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Biopsy (1) · Gemcitabine (1) · Hearing (1) · Interviews as Topic (1) · Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin (1) · Platinum (1) · Practice Guidelines as Topic (1) · Radiotherapy, Image-Guided (1) · Specimen Handling (1) · Standard of Care (1)
Air Force Military Medical University, China (1) · Chinese Academy of Medical Sciences (1) · Emory University (1) · NRG Oncology (1) · National Cancer Institute (NCI) (1)
United States (3) · China (2)
David M Brizel (1) · Junlin Yi, professor (1) · Mei Shi, MD (1) · Nicole C Schmitt, MD, FACS (1) · Vassiliki Saloura (1)
K24DC022077 (1), P30CA138292 (1), UG1CA189867 (1)